Диссертация (1174378), страница 17
Текст из файла (страница 17)
251-252.22. Смирнова, М.А. Бронхиальная астма у детей раннего и дошкольноговозраста:клинико-анамнестическиеипатогенетическиеособенности/М.А.Смирнова // Материалы XIV Конгресса педиатров России с международнымучастием “Актуальные проблемы педиатрии. - Москва, 2010. - С. 735.23. Федеральные клинические рекомендации по диагностике и лечениюбронхиальной астмы / Российское респираторное общество. - 2016. - 55 с.24. Чучалин, А.Г. Генетические аспекты бронхиальной астмы / А.Г.Чучалин //Пульмонология. - 1999.
- № 4. - С. 6-10.25. Чучалин, А.Г. Глобальная стратегия по лечению и профилактикебронхиальной астмы (GINA) / А.Г.Чучалин; под ред. А.Г.Чучалина - М.:Издательский дом «Атмосфера», 2007. - 104 с., ил.26. Чучалин, А.Г. Роль респираторных инфекций в обострениях бронхиальнойастмы / А.Г.Чучалин, Т.П.Оспельникова, Г.Л. Осипова и др. // Пульмонология.
2007. - № 5. - С. 32-34.27. Ярилин, А.А. Иммунология. / А.А.Ярилин. - М.: ГЭОТАР - Медиа, 2010. -749 с.28. Agrawal S. Cutting edge: different toll-like receptor agonists instruct dendriticcells to induce distinct Th responses via differential modulation of extracellular signalregulated kinase- mitogen-activated protein kinase and c-Fos / S. Agrawal, A. Agrawal,B.
Doughty, A. Gerwitz, J. Blenis, T. Van Dyke, B. Pulendran // J Immunol. - 2003. Vol. 171. - P. 4984-4989.29. Anandan C. Is the prevalence of asthma declining? Systematic review ofepidemiological studies / C. Anandan, U. Nurmatov, A. Sheikh // Allergy. - 2010. - Vol.65.
- № 2. - P. 152-167.106 30. Anderson W.C. 3rd. New and future strategies to improve asthma con- trol inchildren / W.C. Anderson 3rd, S.J. Szefler // J Allergy Clin Immunol. - 2015. - Vol.136. - P. 848-859.31. Ank N. An Important Role for Type III Interferon (IFN-λ/IL-28) in TLR-InducedAntiviral Activity / N. Ank, M. Iversen, C. Bartholdy // The Journal of Immunology. 2008. - Vol. 180. - P. 2474-2485.32.
Ank N. Lambda interferon (IFN-?), a type III IFN, is induced by viruses and IFNsand displays potent antiviral activity against select virus infections in vivo / N. Ank, H.West, C. Bartholdy, K. Eriksson, A.R. Thomsen, S.R. Paludan // J. Virol. - 2006.
- Vol.80. - P. 4501-4509.33. Aryan Z. A new era of targeting the ancient gatekeepers of the immune system:toll- like agonists in the treatment of allergic rhinitis and asthma / Z. Aryan, S. T.Holgate, D. Radzioch, N. Rezaei // International Archives of Allergy and Immunology.- 2014. - Vol. 164. - №. 1. - P. 46-63.34. Ashino S. CpG-ODN inhibits airway inflammation at effector phase throughdown-regulation of antigen-specific Th2-cell migration into lung / S.
Ashino, D.Wakita, Y. Zhang, K. Chamoto, H. Kitamura, T. Nishimura // InternationalImmunology. - 2008. - Vol. 20. - № 2. - P. 259-266.35. Baiz N., Annesi-Maesano I. Is the asthma epidemic still ascending? Clin ChestMed. 2012; 33 (3): 419–29. Doi: 10.1016/j.ccm. 2012.06.001. Epub 2012 Jul 18.36. Berenson C.S. Impaired innate COPD alveolar macrophage responses and Toll-like receptor-9 polymorphisms / C.S. Berenson, R.L. Kruzel, C.T.
Wrona, M.J.Mammen, S. Sethi // PLoS One. - 2015. - Vol. 9. - P. 1-16.37. Bezemer G.F. Dual role of Toll-like receptors in asthma and chronic obstructivepulmonary disease / G.F. Bezemer, S. Sagar, J. van Bergenhenegouwen, N.A. Georgiou,J. Garssen, A.D. Kraneveld, G. Folkerts // Pharmacol. Rev. - 2012. - Vol. 64. - №2. - P.337-358.38. Bice J. B. Biologic targeted therapy in allergic asthma / J.
B. Bice, E.Leechawengwongs, A. Montanaro // Annals of Allergy, Asthma and Immunology. 2014. - Vol. 112. - №. 2. - P. 108-115.107 39. Bosse Y. Controversy surrounding the increased expression of TGF beta 1 inasthma / Y. Bosse, M. R. Pleszczynski // Respir. Res. - 2007. - Vol. 8. - Article ID 66.40. Bousquet J. Allergic Rhinitis and Its Impact on Asthma (ARIA): achievements in10 years and future needs / J. Bousquet, H.J. Schunemann, B.
Samolinski, et al // JAllergy Clin Immunol. - 2012. - Vol. 130. - № 5. - P. 1049-1062.41. Braun-Fahrlandar C. Environmental exposure to endotoxin and it relation inschool-age children / C. Braun-Fahrlandar, J. Riedler, U. Herz, W. Eder, M. Waser, L.Grize, S. Maisch, D. Carr, F. Gerlach, A. Bufe, R.P. Lauener, R. Schierl, H. Renz, D.Nowak, E. von Mutius // Allergy and Endotoxin Study Team. // Engl J Med. - 2002. Vol.
347. - № 12. - P. 869-877.42. Bullens D.M. Type III IFN-lambda mRNA expression in sputum of adult andschool-aged asthmatics / D.M. Bullens, A. Decraene, E. Dilissen, I. Meyts, B.K. De,L.J. Dupont, J.L. Ceuppens // Clin Exp Allergy. - 2008. - Vol. 38. - № 9. - P. 14591467.43. Bustin SA.
Quantitative real-time RT-PCR-a perspective / S.A. Bustin, V. Benes,T. Nolan, M.W. Pfaffl // J. Mol. Endocrinol. - 2005. - Vol. 34. - № 3. - P. 597-601.44. Cayrol C. IL-33: an alarmin cytokine with crucial roles in innate immunity,inflammation and allergy / C. Cayrol, J. Girard // Curr. Opin. Immunol. - 2014. - Vol.31. - P.
31-37.45. Chen K. The active contribution of Toll-like receptors to allergic airwayinflammation / K. Chen, X. Yi, Y. Liu, W. Gong, T. Yoshimura, J.M. Wang //International Immunopharmacology. - 2011. - Vol. 11. - № 10. - P. 1391-1398.46. Chen Z.G. Neutralization of TSLP inhibits airway remodeling in a murine modelof allergic asthma induced by chronic exposure to house dust mite / Z.G.
Chen, T.T.Zhang, H.T. Li, F.H. Chen, X.L. Zou, J.Z. Ji, H. Chen // PLoS One. - 2013. - Vol. 8. № 1. - Article ID e51268.47. Chiang D.J. Ribavirin or CpG DNA sequence-modulated dendritic cells decreasethe IgE level and airway inflammation / D.J. Chiang, Y.L. Ye, W.L.
Chen, Y.L. Lee,N.Y. Hsu, B.L. Chiang // American Journal of Respiratory and Critical Care Medicine. 2003. - Vol. 168. - № 5. - P. 575-580.108 48. Chuchalin A.G. Chronic respiratory diseases and risk factors in 12 regions of theRussian Federation / A.G.
Chuchalin, N. Khaltaev, N.S. Antonov, D.V. Galkin, L.G.Manakov, P. Antonini, M. Murphy, A.G. Solodovnikov, J. Bousquet, M.H. Pereira, I.V.Demko // Int J Chron Obstruct Pulmon Dis. - 2014. - Vol. 12. - № 9. - P. 963-974.49. Chun E. Toll-like receptor expression on peripheral blood mononuclear cells inasthmatics; implications for asthma management / E. Chun, S.H. Lee, S.Y. Lee.
E.J.Shim, S.H. Cho, K.U. Min, Y.Y. Kim, H.W. Park // Journal of Clinical Immunology. 2010. - Vol. 30. - № 3. - P. 459-464.50. Cirillo I. Allergic patients have more numerous and prolonged respiratoryinfections than nonallergic subjects / I. Cirillo, G. Marseglia, C. Klersy, G. Ciprandi //Allergy. - 2007. - Vol. 62. - № 9.
- P. 1087-1090.51. Corrigan C. Mechanisms of asthma / C. Corrigan // meDicine. - 2008. - Vol. 36.№ 4.52. Cowan D.C. Biomarker-based asthma phenotypes of corticosteroid response / D.C. Cowan, D.R. Taylor, L.E. Peterson, J.O. Cowan, R. Palmay, A. Williamson, J.Hammel, S.C. Erzurum, S.L. Hazen, S.A. Comhair // Journal of Allergy and ClinicalImmunology.
- 2015. - Vol. 135. - № 4. - P. 877-883.53. Contoli M. Role of deficient type III interferon- λ production in astmaexacerbations / M. Contoli, S. Message // Nature medicinе. - 2006. - Vol. 9. - P. 10231026.54. Cookson W. The immunogenetics of asthma and eczema: a new focus on theepithelium / W.
Cookson // Nat Rev Immunol. - 2004. - Vol. 4. - № 12. - P. 978-988.55. Crespo-Lessmann A. Expression of toll-like receptors 2 and 4 in subjects withasthma by total serum IgE level / A. Crespo-Lessmann, E. Mateus, S. Vidal, D. RamosBarbón, M. Torrejón, J. Giner, L. Soto, C. Juárez, V. Plaza // Respir Res. - 2016. - Vol.17. - P. 41.56. Dillon S. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, viainduction of extracellular signal-regulated kinase mitogen-activated protein kinase andc-Fos in dendritic cells / S.
Dillon, A. Agrawal, T. Van Dyke, G. Landreth, L.109 McCauley, A. Koh, C. Maliszewski, S. Akira, B. Pulendran // J Immunol. - 2004. - Vol.172. - № 8. - P. 4733-4743.57. Dong Z. Holding the Inflammatory System in Check: TLRs and Their TargetedTherapy in Asthma / Z. Dong, L. Xiong, W. Zhang, P.G.
Gibson, T. Wang, Y. Lu, G.Wang, H. Li, F. Wang // Mediators Inflamm. - 2016. - Vol. 2016. - Article ID 2180417.58. Drake M. G. The therapeutic potential of Toll-like receptor 7 stimulation inasthma / M. G. Drake, E. H. Kaufman, A. D. Fryer, D. B. Jacoby // Inflammation &Allergy - Drug Targets. 2012.
- Vol. 11. - № 6. - P. 484-491.59. Duechs M.J. TLR agonist mediated suppression of allergic responses isassociated with increased innate inflammation in the airways / M.J. Duechs, C. Hahn, E.Benediktus, M. Werner-Klein, A. Braun, H.G. Hoymann, F. Gantner, K.J. Erb // PulmPharmacol Ther. - 2011. - Vol.
24. - № 2. - P. 203-214.60. Endo Y. The interleukin-33-p38 kinase axis confers memory T helper 2 cellpathogenicity in the airway / Y. Endo, K. Hirahara, T. Iinuma, K. Shinoda, D.J. Tumes,H.K. Asou, N. Matsugae, K. Obata-Ninomiya, H. Yamamoto, S. Motohashi, K. Oboki,S. Nakae, H. Saito, Y. Okamoto, T. Nakayama // Immunity. - 2015. - Vol. 42.
![](https://s.studizba.com/z.php?f=/templates/si/i/noavatar.png&w=100&h=100&t=1"){kind=avatar}
